Investor Relations

Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura®.

ProNeura®

Titan's proprietary long-term, drug delivery platform provides continuous drug release and non-fluctuating medication levels over a period of six months or longer depending on drug characteristics. ProNeura products are subdermal implants that are intended for treating chronic diseases for which the maintenance of stable medication levels could offer advantages over other routes of administration.

October 16, 2023

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

Read Press Release

December 27, 2023 • 9:00AM EST

Special Meeting of Stockholders

IR Calendar

Q3 2023

Quarterly Results

September 30, 2023

PDF HTML

10-Q

HTML

Financials

ZIP XLS HTML

XBRL

Titan Pharmaceuticals, Inc. Nasdaq: TTNP

Volume

Day Low/High

52 Week Low/High

Titan is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases for which steady state delivery of a drug provides the potential for an efficacy and/or safety benefit. Titan's lead product in development is an implant for the treatment of moderate-to severe-chronic pruritus.

View Presentation

David E. Lazar

Interim Chairman of the Board of Directors and Chief Executive Officer

David E. Lazar has served as the Chief Executive Officer of Custodian Ventures LLC, a company which specializes in assisting distressed public companies through custodianship, since February 2018, and Activist Investing LLC, an actively…

View Full Bio

Kate Beebe DeVarney, Ph.D.

President and Chief Operating Officer

Dr. DeVarney has served as a Director of Titan’s Board of Directors since 2019 and in October 2020, she became Titan’s President and Chief Operating Officer. She previously served as Chief Scientific Officer and has been with the…

View Full Bio

Kate Beebe DeVarney, Ph.D.

President and Chief Operating Officer

View Full Bio

Dato’ Seow Gim Shen

Chairman of the Board of Directors

Dato’ Seow Gim Shen obtained his Bachelor of Multimedia from Swinburne University of Technology in 2005. Dato’ Seow is an expert in IT development industry with more than 15 years of experience. Dato’ Seow also serves as the chairman…

View Full Bio

Avraham Ben-Tzvi

Mr. Ben-Tzvi is the Founder of ABZ Law Office, a boutique Israeli law firm specializing in outsourced general counsel services for publicly traded as well as private companies and corporations, Investments & Securities Laws, Commercial…

View Full Bio

Eric Greenberg

Mr. Greenberg has over 40 years of capital markets experience. As a trader and portfolio manager at hedge funds, his areas of expertise included the development of trading strategies, portfolio management and deal structuring. Mr.…

View Full Bio

David Natan

Mr. Natan currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. In…

View Full Bio

Matthew C. McMurdo

Mr. McMurdo currently serves as Managing Member of McMurdo Law Group, LLC, a corporate and securities law practice, since 2010. Previously, Mr. McMurdo was a Partner at Nannarone & McMurdo, LLP, a boutique law firm, from 2008 to 2010.…

View Full Bio

Brynner Chiam

Brynner Chiam obtained his Bachelor of Business Studies (Accountancy) from Massey University in 1998. Since November 2020, he has held the position of vice president of finance and tax at Black Chamber Management Sdn Bhd where he oversees…

View Full Bio